Dr. William Reha, MD

NPI: 1689632960
Total Payments
$860.91
2023 Payments
$42.83
Companies
8
Transactions
11
Medicare Patients
2,124
Medicare Billing
$222,685

Payment Breakdown by Category

Consulting$339.00 (39.4%)
Education$246.17 (28.6%)
Food & Beverage$175.74 (20.4%)
Other$100.00 (11.6%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $339.00 1 39.4%
Education $246.17 5 28.6%
Food and Beverage $175.74 4 20.4%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $100.00 1 11.6%

Top Paying Companies

Company Total Records Latest Year
Covidien LP $339.00 1 $0 (2017)
Astellas Pharma US Inc $281.65 4 $0 (2023)
SANOFI-AVENTIS U.S. LLC $100.00 1 $0 (2017)
Allergan Inc. $65.95 1 $0 (2017)
Ferring Pharmaceuticals Inc. $35.83 1 $0 (2019)
PFIZER INC. $14.63 1 $0 (2019)
Endo Pharmaceuticals Inc. $12.25 1 $0 (2019)
Janssen Pharmaceuticals, Inc $11.60 1 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2023 $42.83 1 Astellas Pharma US Inc ($42.83)
2022 $88.99 1 Astellas Pharma US Inc ($88.99)
2019 $74.31 4 Ferring Pharmaceuticals Inc. ($35.83)
2018 $149.83 2 Astellas Pharma US Inc ($149.83)
2017 $504.95 3 Covidien LP ($339.00)

All Payment Transactions

11 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
04/29/2023 Astellas Pharma US Inc Xtandi (Drug) Food and Beverage In-kind items and services $42.83 General
Category: Oncology
03/04/2022 Astellas Pharma US Inc Education In-kind items and services $88.99 General
11/06/2019 Endo Pharmaceuticals Inc. EDEX (Drug), XIAFLEX Food and Beverage In-kind items and services $12.25 General
Category: UROLOGY
09/24/2019 PFIZER INC. XTANDI (Drug) Education In-kind items and services $14.63 General
Category: ONCOLOGY
05/05/2019 Ferring Pharmaceuticals Inc. Food and Beverage In-kind items and services $35.83 General
03/26/2019 Janssen Pharmaceuticals, Inc Erleada (Drug) Education In-kind items and services $11.60 General
Category: Oncology
12/13/2018 Astellas Pharma US Inc Education In-kind items and services $65.00 General
10/05/2018 Astellas Pharma US Inc XTANDI (Drug) Food and Beverage In-kind items and services $84.83 General
Category: ONCOLOGY
08/07/2017 SANOFI-AVENTIS U.S. LLC JEVTANA (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $100.00 General
Category: ONCOLOGY
06/26/2017 Covidien LP Valleylab FT10 (Device) Consulting Fee Cash or cash equivalent $339.00 General
Category: Hardware
05/15/2017 Allergan Inc. BOTOX (Biological) Education In-kind items and services $65.95 General

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 8 536 870 $110,360 $58,814
2022 7 514 811 $93,345 $52,746
2021 7 523 853 $98,770 $56,280
2020 6 551 907 $101,210 $54,846
Total Patients
2,124
Total Services
3,441
Medicare Billing
$222,685
Procedure Codes
28

All Medicare Procedures & Services

28 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 305 528 $50,160 $32,401 64.6%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 75 133 $19,950 $11,712 58.7%
52000 Diagnostic exam of bladder and urethra using an endoscope Office 2023 22 23 $12,650 $4,216 33.3%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 32 32 $9,020 $3,739 41.5%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 29 29 $6,720 $1,970 29.3%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2023 43 68 $5,440 $1,864 34.3%
99231 Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes Facility 2023 18 44 $3,300 $1,681 50.9%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 12 13 $3,120 $1,231 39.5%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 302 507 $43,795 $29,831 68.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 68 110 $15,530 $9,608 61.9%
52000 Diagnostic exam of bladder and urethra using an endoscope Office 2022 21 22 $12,100 $4,416 36.5%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 29 29 $7,020 $3,008 42.8%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 41 41 $7,440 $2,885 38.8%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2022 42 62 $4,460 $1,774 39.8%
99231 Follow-up hospital inpatient care per day, typically 15 minutes Facility 2022 11 40 $3,000 $1,225 40.8%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 305 537 $45,645 $31,717 69.5%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 84 132 $18,480 $11,805 63.9%
52000 Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope Office 2021 25 28 $15,400 $4,728 30.7%
99203 New patient outpatient visit, total time 30-44 minutes Office 2021 35 35 $6,300 $2,603 41.3%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 25 25 $6,040 $2,477 41.0%
99212 Established patient outpatient visit, total time 10-19 minutes Office 2021 37 59 $4,130 $1,811 43.9%
99231 Subsequent hospital inpatient care, typically 15 minutes per day Facility 2021 12 37 $2,775 $1,138 41.0%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 302 568 $48,280 $30,897 64.0%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 82 137 $19,180 $10,387 54.2%
99212 Established patient office or other outpatient visit, typically 10 minutes Office 2020 80 113 $7,910 $3,765 47.6%

About Dr. William Reha, MD

Dr. William Reha, MD is a Urology healthcare provider based in Woodbridge, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1689632960.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Reha, MD has received a total of $860.91 in payments from pharmaceutical and medical device companies, with $42.83 received in 2023. These payments were reported across 11 transactions from 8 companies. The most common payment nature is "Consulting Fee" ($339.00).

As a Medicare-enrolled provider, Reha has provided services to 2,124 Medicare beneficiaries, totaling 3,441 services with total Medicare billing of $222,685. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.

Practice Information

  • Specialty Urology
  • Location Woodbridge, VA
  • Active Since 05/03/2006
  • Last Updated 06/28/2010
  • Taxonomy Code 208800000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1689632960

Products in Payments

  • Valleylab FT10 (Device) $339.00
  • JEVTANA (Drug) $100.00
  • XTANDI (Drug) $99.46
  • BOTOX (Biological) $65.95
  • Xtandi (Drug) $42.83
  • EDEX (Drug) $12.25
  • Erleada (Drug) $11.60

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Urology Doctors in Woodbridge